 |
市場調査レポート
商品コード
1373838
細胞表面マーカーの世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測（2023年～2030年）Global Cell Surface Markers Market Size, Share, Growth Analysis, By Type(Flow cytometers, hematology anlayzers and reagents and kits), By Application(Disease diagnosis and identification and research/drug discovery) - Industry Forecast 2023-2030 |
||||||
| 細胞表面マーカーの世界市場 - 市場規模、シェア、成長分析：タイプ別、用途別 - 業界予測（2023年～2030年） |
|
出版日: 2023年10月26日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界細胞表面マーカーの市場規模は、2021年に259億2,000万米ドル、2022年に279億9,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に8%のCAGRで拡大し、2030年には518億1,000万米ドルに成長する見通しです。
世界の細胞表面マーカー市場は急速に成長するダイナミックな産業であり、医学研究、診断、医薬品開発など様々な分野で重要な役割を果たしています。細胞表面マーカーは、細胞表面抗原や分化クラスタ（CD）マーカーとしても知られ、細胞の外表面に存在するタンパク質や分子で、特定の細胞タイプを識別するタグの役割を果たします。これらのマーカーは、さまざまな細胞集団の同定、分離、特性解析に広く利用され、細胞機能、疾病メカニズム、治療標的の理解を助ける。この市場を牽引しているのは、慢性疾患の増加、個別化医療に対する需要の高まり、フローサイトメトリーやその他の細胞分析技術の進歩、研究開発活動への投資の増加といった要因です。さらに、腫瘍学、免疫学、幹細胞研究、感染症などにおける細胞表面マーカーの用途拡大が、市場の成長をさらに後押ししています。しかし、高度な細胞分析機器の高価格や細胞表面マーカー分析の複雑さなどの課題が、市場の可能性を制限しています。とはいえ、多重化・高スループット分析プラットフォームの開発など、現在進行中の技術的進歩は、こうした障壁を克服し、世界の細胞表面マーカー市場の今後の成長を促進する可能性を秘めています。
世界の細胞表面マーカー市場の主要促進要因の1つは、慢性疾患の有病率の上昇です。がん、心血管疾患、自己免疫疾患などの慢性疾患の罹患率が上昇していることが、細胞表面マーカーに対する需要を牽引しています。これらのマーカーは、疾患の診断、予後、標的治療において重要な役割を果たし、個別化医療へのアプローチを助けます。世界中で慢性疾患の負担が増加していることが、高度な細胞分析技術に対する需要を煽り、市場全体の成長を促進しています。
世界の細胞表面マーカー市場の主な抑制要因は、高度な細胞分析機器や技術のコストが高いことです。高度なフローサイトメーター、血液学分析装置、その他の細胞分析プラットフォームに関連する取得コストやメンテナンスコストは、かなりのものになる可能性があります。さらに、細胞表面マーカー分析に使用される試薬やキットのコストも相当なものになります。参入と運用のコストが高いため、特に資源に制約のある環境や新興市場では、高度な細胞分析技術へのアクセスや導入が制限されます。このため、特にコストに敏感なヘルスケアシステムが普及している地域では、市場成長の課題となっています。
当レポートは、世界の細胞表面マーカー市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界の細胞表面マーカー市場、タイプ別
- 市場概要
- フローサイトメーター
- 血液分析装置、試薬、キット
世界の細胞表面マーカー市場、用途別
- 市場概要
- 病気の診断と同定と研究/創薬
世界の細胞表面マーカー市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Thermo Fisher Scientific
- QIAGEN NV
- Bio-Rad Laboratories
- F. Hoffman-La Roche
- BD
- Grifols SA
- GenScript
- Siemens Healthcare Private Limited
- Abcam plc.
- Merck KGaA
- Beckman Coulter, Inc.
- Agilent Technologies
- Sysmex Corporation
- Lonza Group Ltd.
- BioLegend, Inc.
- Novus Biologicals
- Miltenyi Biotec
- Cell Signaling Technology
- Sino Biological Inc.
- R&D Systems
Global Cell Surface Markers Market size was valued at USD 25.92 billion in 2021 and is poised to grow from USD 27.99 billion in 2022 to USD 51.81 billion by 2030, at a CAGR of 8% during the forecast period (2023-2030).
The global cell surface markers market is a rapidly growing and dynamic industry that plays a crucial role in various fields, including medical research, diagnostics, and drug development. Cell surface markers, also known as cell surface antigens or cluster of differentiation (CD) markers, are proteins or molecules present on the outer surface of cells, which serve as identification tags for specific cell types. These markers are extensively utilized in the identification, isolation, and characterization of different cell populations, aiding in the understanding of cell function, disease mechanisms, and therapeutic targeting. The market is driven by factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, advancements in flow cytometry and other cell analysis techniques, and growing investments in research and development activities. Additionally, the expanding applications of cell surface markers in oncology, immunology, stem cell research, and infectious diseases further propel market growth. However, challenges such as the high cost of advanced cell analysis instruments and the complexity of cell surface marker analysis limit the market's full potential. Nevertheless, ongoing technological advancements, such as the development of multiplexed and high-throughput analysis platforms, hold promise for overcoming these barriers and driving the future growth of the global cell surface markers market.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Surface Markers Market Segmental Analysis
Global Cell Surface Markers Market is segmented on the basis of type, application, and region. Based on type, the market can be segmented into Flow cytometers, hematology anlayzers and reagents and kits. Based on application, the market is segmented into Disease diagnosis and identification and research/drug discovery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Cell Surface Markers Market Dynamics
Drivers for Global Cell Surface Markers Market
Increasing prevalence of chronic diseases
One key driver of the global cell surface markers market is the increasing prevalence of chronic diseases. The rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, drives the demand for cell surface markers. These markers play a crucial role in disease diagnosis, prognosis, and targeted therapies, aiding in personalized medicine approaches. The growing burden of chronic diseases worldwide fuels the demand for advanced cell analysis techniques and drives the overall market growth.
Restraints in the Global Cell Surface Markers Market
High cost of advanced cell analysis instruments and techniques
A key restraint of the global cell surface markers market is the high cost of advanced cell analysis instruments and techniques. The acquisition and maintenance costs associated with sophisticated flow cytometers, hematology analyzers, and other cell analysis platforms can be significant. Additionally, the cost of reagents and kits used in cell surface marker analysis can also be substantial. The high cost of entry and operation limits the accessibility and adoption of advanced cell analysis technologies, especially in resource-constrained settings and emerging markets. This poses a challenge for market growth, particularly in regions where cost-sensitive healthcare systems prevail.
Market Trends of Global Cell Surface Markers Key
Increasing focus on personalized medicine
One key market trend in the global cell surface markers market is the increasing focus on personalized medicine. Personalized medicine aims to tailor medical treatments to individual patients based on their unique characteristics, including cell surface markers. Cell surface markers play a vital role in identifying specific cell populations and determining their response to therapies. The growing understanding of the role of cell surface markers in disease progression and treatment response has led to the development of targeted therapies that can be customized based on an individual's cell surface marker profile. This trend towards personalized medicine is driving the demand for advanced cell analysis techniques and innovative cell surface marker detection methods in the market.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Cell Surface Markers Market by Type
- Market Overview
- Flow cytometers
- hematology anlayzers and reagents and kits
- Global Cell Surface Markers Market by Application
- Market Overview
- Disease diagnosis and identification and research/drug discovery
- Global Cell Surface Markers Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffman-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BD (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols SA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthcare Private Limited (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam plc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioLegend, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novus Biologicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Signaling Technology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sino Biological Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- R&D Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
